Celgene (CELG) Holder Nordea Investment Management Ab Trimmed Holding as Stock Price Declined; As Michaels Cos (MIK) Share Value Declined, Shareholder Highfields Capital Management LP Cut by $130.33 Million Its Position

April 25, 2018 - By Marie Mckinney

The Michaels Companies, Inc. (NASDAQ:MIK) Logo

Jonathon Jacobson decreased its stake in Michaels Cos Inc (MIK) by 33.34% based on its latest 2017Q4 regulatory filing with the SEC. Highfields Capital Management Lp sold 5.43M shares as the company’s stock declined 16.88% with the market. The hedge fund run by Jonathon Jacobson held 10.86M shares of the consumer services company at the end of 2017Q4, valued at $262.65M, down from 16.29 million at the end of the previous reported quarter. Highfields Capital Management Lp who had been investing in Michaels Cos Inc for a number of months, seems to be less bullish one the $3.38 billion market cap company. The stock increased 0.43% or $0.08 during the last trading session, reaching $18.59. About 1.20M shares traded. The Michaels Companies, Inc. (NASDAQ:MIK) has declined 10.60% since April 25, 2017 and is downtrending. It has underperformed by 22.15% the S&P500.

Nordea Investment Management Ab decreased its stake in Celgene (CELG) by 12.54% based on its latest 2017Q4 regulatory filing with the SEC. Nordea Investment Management Ab sold 19,141 shares as the company’s stock declined 19.30% with the market. The institutional investor held 133,542 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $13.94 million, down from 152,683 at the end of the previous reported quarter. Nordea Investment Management Ab who had been investing in Celgene for a number of months, seems to be less bullish one the $67.05B market cap company. The stock decreased 0.39% or $0.35 during the last trading session, reaching $89.14. About 3.49 million shares traded. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since April 25, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on May, 4 before the open. They expect $1.77 EPS, up 15.69% or $0.24 from last year’s $1.53 per share. CELG’s profit will be $1.33B for 12.59 P/E if the $1.77 EPS becomes a reality. After $1.87 actual EPS reported by Celgene Corporation for the previous quarter, Wall Street now forecasts -5.35% negative EPS growth.

Investors sentiment decreased to 0.83 in 2017 Q4. Its down 0.34, from 1.17 in 2017Q3. It worsened, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds opened positions while 411 raised stakes. 561.38 million shares or 7.06% less from 603.99 million shares in 2017Q3 were reported. Horan Cap Advsrs Ltd reported 27,353 shares stake. Sectoral Asset Management has invested 3.02% in Celgene Corporation (NASDAQ:CELG). Acg Wealth owns 32,021 shares for 0.49% of their portfolio. Westover Advsrs Ltd holds 17,912 shares or 1.03% of its portfolio. Bartlett Llc invested 0.01% in Celgene Corporation (NASDAQ:CELG). Bb&T has invested 0.04% in Celgene Corporation (NASDAQ:CELG). Metropolitan Life Ins New York has 154,974 shares. M&R Capital Mgmt owns 0.04% invested in Celgene Corporation (NASDAQ:CELG) for 1,565 shares. Amundi Pioneer Asset Management Inc holds 0.13% of its portfolio in Celgene Corporation (NASDAQ:CELG) for 814,675 shares. Boston Ptnrs holds 0.02% or 150,174 shares in its portfolio. Bnp Paribas Asset Mngmt Sa holds 1.18M shares or 1.05% of its portfolio. Moreover, Atalanta Sosnoff Capital has 0.01% invested in Celgene Corporation (NASDAQ:CELG) for 2,084 shares. Horizon Invest Service Llc holds 19,922 shares. Connor Clark Lunn Inv Mgmt owns 331,993 shares for 0.2% of their portfolio. Greenwood Associate Limited Liability stated it has 0.55% of its portfolio in Celgene Corporation (NASDAQ:CELG).

Nordea Investment Management Ab, which manages about $42.34B US Long portfolio, upped its stake in Newfield Exploration (NYSE:NFX) by 325,567 shares to 441,549 shares, valued at $13.92M in 2017Q4, according to the filing. It also increased its holding in Bioverativ by 11,008 shares in the quarter, for a total of 48,387 shares, and has risen its stake in Hp.

Since February 8, 2018, it had 1 insider buy, and 3 selling transactions for $3.58 million activity. $1.77M worth of Celgene Corporation (NASDAQ:CELG) was sold by KAPLAN GILLA. $1.26M worth of Celgene Corporation (NASDAQ:CELG) was sold by MARIO ERNEST on Friday, February 23. LOUGHLIN JAMES J had sold 9,250 shares worth $851,093.

Among 34 analysts covering Celgene Corporation (NASDAQ:CELG), 19 have Buy rating, 1 Sell and 14 Hold. Therefore 56% are positive. Celgene Corporation had 142 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Hold” rating by Robert W. Baird given on Wednesday, February 28. Morgan Stanley downgraded the stock to “Underweight” rating in Thursday, October 5 report. On Friday, November 6 the stock rating was maintained by Canaccord Genuity with “Buy”. The rating was downgraded by SunTrust to “Hold” on Wednesday, February 28. The stock has “Hold” rating by Bank of America on Friday, January 5. The company was maintained on Thursday, September 7 by Stifel Nicolaus. Canaccord Genuity maintained Celgene Corporation (NASDAQ:CELG) on Friday, October 27 with “Buy” rating. The rating was maintained by UBS with “Buy” on Friday, November 6. The rating was maintained by Cantor Fitzgerald on Friday, July 24 with “Buy”. On Friday, October 20 the stock rating was maintained by Leerink Swann with “Buy”.

Highfields Capital Management Lp, which manages about $22.71B and $12.03B US Long portfolio, upped its stake in Shire Plc (NASDAQ:SHPG) by 607,500 shares to 795,000 shares, valued at $123.32M in 2017Q4, according to the filing. It also increased its holding in Monsanto Co New (NYSE:MON) by 693,537 shares in the quarter, for a total of 5.98M shares, and has risen its stake in Tesla Inc (NASDAQ:TSLA).

Among 19 analysts covering Michaels Companies Inc (NASDAQ:MIK), 13 have Buy rating, 2 Sell and 4 Hold. Therefore 68% are positive. Michaels Companies Inc had 44 analyst reports since August 25, 2015 according to SRatingsIntel. Morgan Stanley downgraded The Michaels Companies, Inc. (NASDAQ:MIK) on Monday, March 7 to “Equal-Weight” rating. As per Thursday, March 22, the company rating was maintained by Guggenheim. The stock of The Michaels Companies, Inc. (NASDAQ:MIK) earned “Buy” rating by Goldman Sachs on Thursday, January 21. Bank of America maintained The Michaels Companies, Inc. (NASDAQ:MIK) on Friday, June 16 with “Buy” rating. The company was upgraded on Monday, July 24 by J.P. Morgan. The rating was maintained by Piper Jaffray on Thursday, March 22 with “Sell”. Deutsche Bank maintained The Michaels Companies, Inc. (NASDAQ:MIK) rating on Wednesday, December 7. Deutsche Bank has “Buy” rating and $28 target. The stock of The Michaels Companies, Inc. (NASDAQ:MIK) earned “Overweight” rating by Morgan Stanley on Friday, March 23. The rating was maintained by SunTrust on Monday, October 16 with “Buy”. Deutsche Bank downgraded it to “Hold” rating and $25.0 target in Tuesday, December 12 report.

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Marie Mckinney

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts